Journal: iScience
Article Title: Characterizing replisome disassembly in human cells
doi: 10.1016/j.isci.2024.110260
Figure Lengend Snippet: CUL2 or LRR1 depletion leads to replisome retention on the chromatin (A) CUL2 downregulation by siRNA. U2OS cells were transfected with Non-T or CUL2 siRNA (two sequences used in combination; see Oligonucleotides in ) for 48 or 72 h. Whole-cell extract samples were then analyzed by western blotting with the indicated antibodies. (B) CDC45 accumulates on chromatin in S-phase upon depletion of CUL2. Asynchronous U2OS cells transfected with Non-T or CUL2 siRNA for 72 h were analyzed by immunofluorescence. Shown is the quantification of total chromatin-bound CDC45 intensity in EdU-positive (S-phase) cells ( n = 4) (AVG > 295 cells/sample). Red lines indicate the median (p=<0.0001, Two-tailed Mann-Whitney test). (C) Same as for (B) but in CENPF-positive (G2) cells ( n = 4) ( p = 0.0076, Two-tailed Mann-Whitney test) (AVG > 80 cells/sample). (D) Same as for (C) but quantification of the percentage of G2 cells with CDC45 signal above the median of Non-Tsi level ( n = 4) ( p = 0.0009, Two-tailed unpaired t test); mean value +/− SEM. (E) Degradation of mAC-LRR1 after 24 h of auxin treatment. Whole-cell extracts of HCT116-OsTIR1 cells expressing mAC-LRR1 were incubated with GFP-Trap Magnetic Agarose and samples analyzed by western blotting with indicated antibodies. (F) MCM7 accumulates on chromatin in G2 cells upon mAC-LRR1 depletion. HCT116 LRR1-mAC cells were treated with DOX for 48 h and ±IAA for 24 h and analyzed by immunofluorescence. Shown is the quantification of chromatin-bound MCM7 intensity in CENPF-positive (G2) cells ( n = 3) (AVG > 70 cells/sample). Red lines indicate the median (p=<0.0001, Two-tailed Mann-Whitney test). (G) Same as for (F) but quantification of the percentage of G2 cells with MCM7 signal above the median of -IAA cells ( n = 3) ( p = 0.0359, Two-tailed unpaired t test); mean value +/− SEM. (H) Ubiquitylation of MCM7 on chromatin is reduced in S-phase following LRR downregulation. HCT116 LRR1-mAC cells were treated with DOX for 48 h, transfected with HIS-Ubi plasmid, synchronized with STB and released for 6 h ± IAA. HIS-tagged proteins were isolated using the HIS pull-down assay and samples analyzed by western blotting with the indicated antibodies. Levels of MCM7 ubiquitylation were then quantified using ImageJ. Mean ± SEM ( n = 4) ( p = 0.0145, Two-tailed paired t test). (I) CMG components accumulate on chromatin in synchronized cells upon LRR downregulation. U2OS cells were transfected with Non-T or LRR1 siRNA (see Oligonucleotides in ), synchronized with DTB and then released for indicated time points, with addition of NZ at 8 h. Chromatin was extracted with CSK buffer and samples analyzed by western blotting with indicated antibodies. (J) CDC45 accumulates on chromatin in G2 cells upon LRR1 downregulation. Asynchronous U2OS cells transfected with Non-T or LRR1 siRNA for 72 h were analyzed by immunofluorescence. Shown is the quantification of total chromatin-bound CDC45 intensity in CENPF-positive (G2) cells ( n = 3) (p=<0.0001, Two-tailed Mann-Whitney test) (AVG > 60 cells/sample). Red lines indicate the median. (K) Same as for (J) but quantification of the percentage of G2 cells with CDC45 signal above the median of Non-Tsi control cells ( n = 3) ( p = 0.0417, Two-tailed unpaired t test); mean value +/− SEM. (L) MCM7 accumulates on G2 chromatin upon LRR1 downregulation. Whole-cell extracts of HEK293T cells inducibly expressing LRR1 shRNA (see ) for 6 days were analyzed by western blotting with indicated antibodies. Also shown is the representative immunofluorescence images of chromatin-bound pH3-S10 and MCM7 in G2-phase cells expressing LRR1 shRNA.
Article Snippet: For pulling down mAC-LRR1, 1 mg chromatin lysates were incubated with 25 μL GFP-Trap Magnetic Agarose (Chromotek) for 2 h at 4°C with rotation.
Techniques: Transfection, Western Blot, Immunofluorescence, Two Tailed Test, MANN-WHITNEY, Expressing, Incubation, Plasmid Preparation, Isolation, Pull Down Assay, Control, shRNA